
Transactions: Share issues and placements
Filter


Secondary placement of shares in Karo Bio (SE) — SEK 96 million

Rights offering in Medivir (SE) — SEK 325 million

Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million

Secondary placing of 6 million shares in PA Resourcres (NO) — NOK 309 million

Rights issue in TK Development (DK) — DKK 561 million

New share issue in Aktiv Kapital ASA (NO) — NOK 134 million

Secondary placing of 6 million shares in Intrum Justitia (SE) — SEK 510 million

New share issue in Axis Biochemicals ASA (NO) — NOK 72 million

New share issue and IPO in Clavis Pharma ASA (NO) — NOK 242 million

Directed new share issue in Clavis Pharma ASA (NO) — NOK 154 million
